subscribeSubscribe
FDA approves J&J`s combination therapy for a type of lung cancer

FDA approves J&J`s combination therapy for a type of lung cancer
REUTERS
02 Mar 2024
Share Share
Lilly`s Retevmo bests Keytruda combo in front-line RET-rearranged lung cancer

Lilly`s Retevmo bests Keytruda combo in front-line RET-rearranged lung cancer
PRESS RELEASE
05 Aug 2023
Share Share
Intas Pharmaceuticals Limited on FDA Import Alert List

Intas Pharmaceuticals Limited on FDA Import Alert List
FDA
06 Jun 2023
Share Share
Lantern Pharma Selects REPROCELL USA to & Support for the pH 2 Harmonic™

Lantern Pharma Selects REPROCELL USA to & Support for the pH 2 Harmonic™
BUSINESSWIRE
03 May 2023
Share Share
Baxter`s Pemetrexed Receives Approval in Europe

Baxter`s Pemetrexed Receives Approval in Europe
EMA
19 Jan 2023
Share Share
Lotus acquires Alimta in Taiwan from Eli Lilly for $62 M

Lotus acquires Alimta in Taiwan from Eli Lilly for $62 M
BIOSPECTRUMASIA
15 Dec 2022
Share Share
Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination

Junshi Biosciences Receives NMPA Approval of sNDA for Toripalimab in Combination
GLOBENEWSWIRE
20 Sep 2022
Share Share
Lantern Pharma Reports Second Quarter 2022 Financial Results

Lantern Pharma Reports Second Quarter 2022 Financial Results
BUSINESS WIRE
08 Aug 2022
Share Share
HERTHENA-Lung02 PIII Trial of Patritumab Deruxtecan Initiated in Patients

HERTHENA-Lung02 PIII Trial of Patritumab Deruxtecan Initiated in Patients
BUSINESS WIRE
08 Aug 2022
Share Share
Eli Lilly`s Alimta plunges as new launches shine

Eli Lilly`s Alimta plunges as new launches shine
Eric Sagonowsky FIERCEPHARMA
04 Aug 2022
Share Share